GenAssist Therapeutics
Suzhou
About GenAssist Therapeutics
GenAssist Therapeutics develops gene therapy drugs using base editing technology, which is advantageous in the field of DMD treatment. Founded in 2020, GenAssist was founded by outstanding scientists and industry experts in July 2020. They are committed to the development of gene editing drugs for a variety of genetic diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Funding stage: Early Stage Venture
- Last round: Series A (Dec 2022)
- Website: genassisttx.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/genassist-therapeutics-2988073 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.